Treatment of thrombotic thrombocytopenic purpura
β Scribed by Menno van der Straaten; Sophie Jamart; Robert Wens; Philippe Gottignies; Max Dratwa; Jacques Devriendt
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 80 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1432-1238
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Five patients with thrombotic thrombocytopenic purpura (TTP) were treated with corticosteroids, plasma exchange (PE), and antiplatelet agents. ABO-and Rh-compatible fresh-frozen plasma (FFP) was used as the replacement fluid. None of the patients received FFP infusion without PE. The patients were
Plasma exchange (PE) is considered first-line treatment for thrombotic thrombocytopenic purpura (TTP) to the point that many clinicians regard it as definitive therapy. Studies have reported response rates to PE ranging from 39% to 78%. In our experience, a minority of patients have been cured solel